Viruend, a breakthrough filtration material, captures and kills SARS-CoV-2

How Viruend works.png

Invented in Hawaii, Viruend captures and kills SARS-CoV-2 and all its variants

Senturion+ announced that its patented Viruend™ filtration material has been proven to block and inactivate the SARS-CoV-2 virus with a 98.8% removal efficacy rate. Scientists from the Battelle Memorial Institute, a private nonprofit applied science and technology laboratory, tested Viruend in a composited paper media against live SARS-CoV-2 and determined that it significantly exceeds the filtration capabilities of standard N95 masks.

Liangjie Dong, a University of Hawaii scientist whose background includes bioengineering, chemistry, and soil sciences, invented and patented a heavy metals filtration technology made from a natural clay mineral manufactured into ceramic granules and powder of clay. Tests shows that this patented technology can also both filter and deactivate airborne viruses of <3 nanometers, including SARS-CoV-2.

Viruend can easily be been integrated into N-95 masks, medical protective gowns, and HEPA filters for HVAC systems. Viruend is already available commercially in China, and so now the team is readying Viruend for the U.S. market.

Viruend has the potential to be a next-generation of filtration technology that will become a tool to fight virus-based pandemics today and in the future.

Viruend can be a game-changer for manufacturers of masks, HEPA air filters, and other air-filtration material designed to protect against SARS-CoV-2 and other viruses. Recent reports from the CDC and EPA identify airborne transmission of the SARS-CoV-2 virus as the most common route of spreading COVID-19. We are eager to partner with filtration companies to deploy this potentially life-saving medical countermeasure against the spread of COVID-19, its mutations, and future infectious viruses.
— Senturion+ CEO Ted Liu


ZingPR launched Viruend on a project basis

While most PR firms require lengthy retainer-based contracts, we’re happy to engage with clients on a short-term basis. For this project, we assisted with overall positioning, developed the news release, researched and formulated a broad list of industrial and medical journalists to target, and then conducted thorough media outreach and pitching.

Initial results are feature stories in Hawaii’s top business journal (Pacific Business News) and Medical Design Briefs, a publication that focuses on early-stage medical technologies.

Thinking about an upcoming announcement and would like to strategize with PR experts? We’d love to help!

Previous
Previous

Jifflenow CMO Ravi Chalaka is a featured guest on the DemandGen Report podcast

Next
Next

CureLab Oncology forms veterinary oncology subsidiary to fight pet cancer